AZTREONAM LYSINE: 11,694 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
11,694
Total FAERS Reports
1,352 (11.6%)
Deaths Reported
8,024
Hospitalizations
11,694
As Primary/Secondary Suspect
14
Life-Threatening
78
Disabilities
First Report: 1118 · Latest Report: 20250923
What Are the Most Common AZTREONAM LYSINE Side Effects?
#1 Most Reported
Cystic fibrosis
2,766 reports (23.7%)
#2 Most Reported
Off label use
1,398 reports (12.0%)
#3 Most Reported
Pneumonia
1,180 reports (10.1%)
All AZTREONAM LYSINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cystic fibrosis | 2,766 | 23.7% | 107 | 2,160 |
| Off label use | 1,398 | 12.0% | 217 | 803 |
| Pneumonia | 1,180 | 10.1% | 25 | 948 |
| Death | 1,061 | 9.1% | 1,061 | 89 |
| Infection | 760 | 6.5% | 7 | 621 |
| Lung disorder | 543 | 4.6% | 24 | 501 |
| Lung transplant | 499 | 4.3% | 18 | 271 |
| Cystic fibrosis respiratory infection suppression | 440 | 3.8% | 1 | 436 |
| Condition aggravated | 431 | 3.7% | 4 | 389 |
| Dyspnoea | 391 | 3.3% | 11 | 324 |
| Infective pulmonary exacerbation of cystic fibrosis | 385 | 3.3% | 16 | 314 |
| Pseudomonas infection | 314 | 2.7% | 3 | 155 |
| Cough | 281 | 2.4% | 1 | 153 |
| Malaise | 272 | 2.3% | 8 | 227 |
| Pulmonary function test decreased | 252 | 2.2% | 2 | 229 |
| Influenza | 251 | 2.2% | 4 | 223 |
| Haemoptysis | 233 | 2.0% | 15 | 201 |
| Lung infection | 198 | 1.7% | 3 | 161 |
| Intentional dose omission | 148 | 1.3% | 2 | 115 |
| Covid-19 | 129 | 1.1% | 3 | 104 |
Who Reports AZTREONAM LYSINE Side Effects? Age & Gender Data
Gender: 60.2% female, 39.8% male. Average age: 33.8 years. Most reports from: US. View detailed demographics →
Is AZTREONAM LYSINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 0 |
| 2007 | 1 | 0 | 1 |
| 2010 | 7 | 1 | 4 |
| 2011 | 20 | 12 | 8 |
| 2012 | 27 | 15 | 11 |
| 2013 | 50 | 28 | 20 |
| 2014 | 152 | 93 | 47 |
| 2015 | 219 | 74 | 130 |
| 2016 | 219 | 60 | 157 |
| 2017 | 344 | 66 | 244 |
| 2018 | 733 | 70 | 592 |
| 2019 | 1,058 | 69 | 852 |
| 2020 | 509 | 48 | 346 |
| 2021 | 464 | 43 | 346 |
| 2022 | 291 | 37 | 187 |
| 2023 | 210 | 37 | 111 |
| 2024 | 170 | 24 | 102 |
| 2025 | 93 | 28 | 55 |
What Is AZTREONAM LYSINE Used For?
| Indication | Reports |
|---|---|
| Cystic fibrosis | 8,046 |
| Pseudomonas infection | 2,884 |
| Cystic fibrosis lung | 1,883 |
| Product used for unknown indication | 767 |
| Bronchiectasis | 720 |
| Infective pulmonary exacerbation of cystic fibrosis | 185 |
| Infective exacerbation of bronchiectasis | 93 |
| Illness | 92 |
| Bacterial disease carrier | 85 |
| Bacterial infection | 81 |
AZTREONAM LYSINE vs Alternatives: Which Is Safer?
AZTREONAM LYSINE vs BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN
AZTREONAM LYSINE vs BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
AZTREONAM LYSINE vs BACITRACIN
AZTREONAM LYSINE vs BACITRACIN\NEOMYCIN\POLYMYXIN B
AZTREONAM LYSINE vs BACITRACIN\POLYMYXIN B
AZTREONAM LYSINE vs BACLOFEN
AZTREONAM LYSINE vs BACLOFEN INTRATHECAL
AZTREONAM LYSINE vs BACTRIM
AZTREONAM LYSINE vs BALOXAVIR MARBOXIL
AZTREONAM LYSINE vs BALSALAZIDE
Official FDA Label for AZTREONAM LYSINE
Official prescribing information from the FDA-approved drug label.